Research on depression and its treatment. Covers stress-response biology, ketamine and dopamine-targeting therapies, treatment-resistant cases, and brain mechanisms.
Teens who fight with siblings over equality and fairness issues are more depressed a year later, while those who fight about personal space issues have lower self-esteem. Younger brothers with older brothers and girls with brothers experience more anxiety, leading to lower self-esteem.
Scientists have discovered that a specific region of the brain, the ventral tegmental area, plays a key role in both inducing and relieving depression-like symptoms. By controlling this region with light stimulation, researchers were able to reverse depressed states in mice, providing new hope for future treatments.
A clinical trial by NIH found that AZD6765 briefly improved depression symptoms in minutes, with fewer side effects than ketamine, and better residual effects.
Researchers found that older adults who reported better well-being had higher education, cognitive function and lower depression levels. The study suggests an optimistic approach to caring for seniors can help reduce ageism and improve outcomes.
A large-scale trial found that cognitive behavioral therapy (CBT) provided in addition to usual care reduced symptoms of depression and improved patients' quality of life. At six months, 46% of those who received CBT had improved, reporting at least a 50% reduction in symptoms.
Researchers at King's College London identified the 'Hedgehog pathway' regulating stress hormones and brain cell development. The study revealed that inhibiting this pathway can reverse damaging effects of stress hormones on brain cells, offering new potential mechanisms to target depression.
GLYX-13 produced statistically significant reductions in depression scores within 24 hours and persisted for an average of seven days. The effect size observed was nearly double the effect size seen with most other antidepressant drugs after 4-6 weeks of repeated dosing.
A recent study published in The Lancet found that Cognitive Behavioral Therapy (CBT) significantly reduced depressive symptoms in adults who had not responded to antidepressant medication. After six months, 46% of participants in the CBT group showed improvement compared to 22% in the control group.
A new study by Emory researchers has proven successful in preventing depression in people with epilepsy, reducing seizures and improving quality of life. The web-based method, called Project UPLIFT, provides patients with depression prevention and stress management skills, increasing knowledge and skills to replace negative feelings.
Researchers analyzed data on individuals with depression across four developmental periods, finding that early episodes last longer and increase risk of future episodes. Female participants were more likely to experience first incidence but not recurrence.
A study found that parents with children living in urban areas are less likely to experience depression than those with children nearby. The key protective factor was the financial support sent by children, which mitigated the empty-nest syndrome.
Researchers discovered a cognitive biomarker in young adolescents at high risk of developing depression and anxiety. The test can help initiate early intervention, which has proven to be an effective way to combat mental illness.
A new study suggests that lack of nutrients like folate and vitamin B12 may be associated with specific subtypes of depression. Melancholic depressive symptoms were linked to lower folate intake, while non-melancholic symptoms were tied to an increased risk of metabolic syndrome.
Researchers at McMaster University discovered a novel molecular basis for depression, finding the FTO gene is associated with an eight per cent reduction in the risk of depression. The study found no link between obesity and depression, contradicting common perception that obese individuals are more likely to be depressed.
Researchers at Butler Hospital and Bradley Hospital found a sharp decline in the availability and use of Electroconvulsive Therapy (ECT) for severe depression in general hospitals across the US. The annual number of hospital stays where ECT was administered fell by 43% over 17 years, from over 1.2 million to 720,000.
Low levels of omega-3 during pregnancy may trigger depressive episodes. Increasing fish consumption could help bring maternal omega-3 levels up to recommended levels, potentially reducing the risk of postpartum depression.
A new study suggests that chronic exposure to bright light at night can lead to depression-like behaviors, including decreased interest in sugar and pleasure seeking, and impaired cognitive function. Treatment with Prozac restored the mice's healthy moods and learning abilities.
Research published by Viren Swami from the University of Westminster found that men and women equally identified Kate's symptoms as indicative of a mental health disorder, but men were less likely to recognize Jack's symptoms. Men also rated Kate's case as more distressing and deserving of sympathy than Jack's.
Research reveals that genes involved in glutamatergic transmission are associated with an increased risk of depression. Drugs targeting the glutamate system may help improve current antidepressant treatment outcomes.
A new study from the University of Michigan found that physicians who commit suicide often have known mental health problems but fail to seek treatment due to stigma and lack of confidentiality. The study highlights the need for greater effort to address job stress, under-diagnosis, and treatment of depression among physicians.
A study by Rhode Island Hospital researcher Mark Zimmerman found that patients and clinicians have distinct definitions of remission from major depressive disorder. Patients prioritize life satisfaction and well-being over symptoms, emphasizing the importance of a patient-centered approach to treatment.
A new study found that reducing symptoms of depression in heart failure patients can improve their physical health, social functioning and quality of life. Participants whose depression remitted had significant improvements on measures of physical health, including endurance.
A twin study found that genes involved in satisfaction and positivity give protection against major depression, with a heritability of 34% for depression and 72% for overall life satisfaction. Environmental factors play a smaller role in protecting against depression than genetic factors.
Over three-quarters of people with depression report experiencing discrimination, which acts as a barrier to social life and employment. Despite this, nearly half of participants who anticipated discrimination found that their experiences did not confirm this.
A new study published in Clinical Psychological Science found that recent exposure to targeted rejection activates inflammatory signaling pathways and elevates pro-inflammatory signaling molecules. Participants with higher perceived social status showed a more pronounced effect, suggesting an adaptive response in top-tier individuals.
Researchers have discovered potential new targets for treating depression by modulating dopamine cells and the innate immune system in mice. Increasing activity of dopamine neurons produced depressed behavior, while inhibiting them eased symptoms.
A new study in rats shows that chronic stress during pregnancy prevents the formation of brain connections associated with learning, memory, and mood. The stressed rats' brains did not exhibit the same level of neural growth as unstressed mother rats, which had increased dendritic spines after giving birth.
Dr. Bowen Chung is conducting two studies to improve mental health care for troubled youths and adolescents, focusing on family therapy and resiliency classes. The first study will test the effectiveness of family-focused therapy in improving treatment outcomes for psychotic and bipolar adolescents.
A new study found that maternal depression treatment with serotonin reuptake inhibitors accelerates babies' language development, while untreated depression prolongs this period. Researchers measured changes in heart rate and eye movement to sounds and video images of native and non-native languages.
Current evidence suggests ketamine regenerates damaged brain cells, providing immediate relief from symptoms in treatment-resistant patients. Understanding its mechanism could lead to the development of a new class of antidepressants.
A study published in Annals of Behavioral Medicine found that gender-specific group therapy reduced depressive symptoms in women with Type 2 diabetes by half compared to usual care. The therapy program, SWEEP, taught participants how blood sugar affects emotions and helped them recognize stress signs.
A study by University of Leicester researchers found that discrimination from managers has the largest impact on anxiety, depression, and emotional exhaustion among mental health workers. Meanwhile, discrimination from patients' visitors causes more distress than from patients themselves.
A new study finds that humanitarian aid workers are at significant risk for mental health problems in the field and after returning home. The risk factors include a history of mental illness, weak social support, and continual exposure to a challenging work environment, rather than experiencing particular dangerous situations.
A study found that 40% of stroke patients were treated for depression without proper diagnosis. Researchers say clinicians are over-treating some patients and overlooking others due to lack of access to mental health care professionals. Screening for depression after all strokes could improve treatment outcomes.
A study published in Psychological Science found that individuals with clinical depression struggle to differentiate between various negative emotions, including anger and frustration. In contrast, healthy individuals tend to identify specific emotions more accurately.
A new article suggests that prejudice can cause depression, with the connection between stereotypes about others and schemas of self being fundamentally similar. Depressed individuals may experience deprejudice, leading to societal, interpersonal, or intrapersonal depression.
A new training program targeting specific memory recall has been shown to alleviate symptoms of depression in adolescents. The study found that participants who received the intervention recalled more specific memories and showed fewer symptoms of depression compared to those in a control group.
A large-scale study found that children with migraine headaches are more likely to experience social and attention issues, as well as anxiety and depression. The study, published in the journal Cephalalgia, suggests that headache frequency is a key factor in these behavioral difficulties.
In 2011, Americans took a record 4.02 billion prescription drugs, with antidepressants and ADHD medicines showing notable increases in sales. The growth of prescriptions is attributed to the rising demand for CNS disorders medications.
A study by CWRU nurse researchers found that the physical, mental, emotional, and time-related cost of home caregiving saps caregivers' energy. Higher effort correlated with higher depressive symptoms in caregivers.
A new study finds that prenatal diagnosis of congenital heart disease (CHD) is associated with increased maternal stress, depression, and anxiety. Healthy coping mechanisms and partner support are crucial for pregnant women to deal with the emotional impact.
Researchers found that a medication inhibiting inflammation showed promise in treating major depression, especially in individuals with high levels of inflammation. The study employed infliximab, an antibody blocking tumor necrosis factor, and demonstrated improved symptoms in subjects with elevated C-reactive protein levels.
A study found that spouses of people who suffer a sudden heart attack are at an increased risk of depression, anxiety, or suicide. Men were more susceptible to depression and suicide after their wife's survival or death from an acute myocardial infarction.
Researchers discovered that fibroblast growth factor-2 (FGF2) can increase the number of glial cells, supporting neurons and promoting proper neuronal function. This study presents a fundamental new mechanism for treating depression by targeting glial cell growth.
Studies investigate the connection between serotonin, BDNF, and TG2 in depression. High levels of TG2 may disrupt serotonin signaling, leading to depressive symptoms.
A Yale research team has identified a single genetic switch that triggers loss of brain connections and contributes to depression. The study found that the transcription factor GATA1 represses genes necessary for synaptic connection formation, disrupting circuits involved in emotion and cognition.
Pregnant women experiencing depression may benefit from mindfulness yoga, which can significantly reduce depressive symptoms and improve attachment to their babies. This study provides promising evidence that yoga could be an effective alternative to pharmaceutical treatment for pregnant women showing signs of depression.
A study found that adding creatine to antidepressant treatment significantly improved response rates, with twice as fast response times and higher remission rates compared to placebo. The supplement may provide a relatively inexpensive treatment option for women who haven't responded well to traditional antidepressants.
Researchers identified a brain signal that can predict which depressed patients will respond to ketamine, a rapid-acting antidepressant. The signal also holds clues to the agent's mechanism of action, which may lead to more personalized treatment.
A large international study found that moderate exercise helps ease depression in patients with chronic heart failure, while also reducing deaths and hospitalizations. The study, published in the Journal of the American Medical Association, suggests that exercise has a significant impact on both mental and physical health.
A novel intervention called Emotion Detectives Treatment Protocol (EDTP) has shown significant reductions in anxiety and depression severity after treatment. The program adapts age-appropriate techniques from adult and adolescent protocols to educate children about emotions, problem-solving skills, and behavior activation.
A study by the University of South Florida College of Nursing found that Accelerated Resolution Therapy (ART) substantially reduced PTSD symptoms, including depression and anxiety, after just one to four sessions. The therapy uses eye movements to process traumatic memories, resulting in a significant improvement in symptoms.
Researchers found a 58% positive response rate and 37% remission rate to TMS in patients with persistent symptoms despite antidepressant use. The study validated the effectiveness of TMS as an alternative treatment option for depression.
A new study suggests that chronic exposure to artificial light at night can lead to depressive symptoms in rodents, which can be reversed by returning to a standard light-dark cycle. The study found that blocking the effects of tumor necrosis factor, a protein involved in depression, prevented the development of depressive-like symptoms.
A meta-analysis of 10 studies found that cognitive behavioral therapy and pharmacologic interventions decrease depressive symptoms in cancer patients. The study also identified effective interventions for different stages of cancer and cultural subpopulations.
A University of Michigan study reveals that spouses of severe sepsis patients are nearly four times more likely to experience substantial depressive symptoms. Greater mental health screenings may be necessary for these individuals to support their loved ones' rehabilitation and decision-making.
The NYC trans fat ban resulted in a significant reduction of trans fat consumption among fast food patrons, with a notable decrease in saturated fat intake. Young women who have never been pregnant are also at risk for urinary incontinence, affecting up to 12.6% of those surveyed. Prophylactic antidepressant therapy may help prevent tr...
A new treatment protocol, Emotion Detectives Treatment Protocol (EDTP), shows significant reduction in anxiety and depression severity after treatment. The program delivers education about emotions, strategies for evaluating situations, problem solving skills, behavior activation, and parent training.
Researchers at Stanford University School of Medicine have identified a novel molecular mechanism responsible for anhedonia, the loss of pleasure in major depression. The study's findings suggest that targeting a hormone known to affect appetite may be a promising approach to treating depression.
Bill C-31 could have serious negative impacts on the mental health of refugees, with proposals to separate children from their parents and delay family reunification. Detention reviews will not occur for six months after initial two-week review, potentially exacerbating depression and anxiety in vulnerable individuals.